Anna-Maria Larsson

1.2k total citations
27 papers, 859 citations indexed

About

Anna-Maria Larsson is a scholar working on Oncology, Cancer Research and Immunology. According to data from OpenAlex, Anna-Maria Larsson has authored 27 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 11 papers in Cancer Research and 6 papers in Immunology. Recurrent topics in Anna-Maria Larsson's work include Cancer Cells and Metastasis (11 papers), Cancer Genomics and Diagnostics (6 papers) and Breast Cancer Treatment Studies (5 papers). Anna-Maria Larsson is often cited by papers focused on Cancer Cells and Metastasis (11 papers), Cancer Genomics and Diagnostics (6 papers) and Breast Cancer Treatment Studies (5 papers). Anna-Maria Larsson collaborates with scholars based in Sweden, Czechia and United States. Anna-Maria Larsson's co-authors include Lisa Rydén, Pär‐Ola Bendahl, Kristina Aaltonen, Sara Jansson, Karin Leandersson, Caroline Bergenfelz, Karin Jirström, Birger Åstedt, Göran Landberg and Sven Påhlman and has published in prestigious journals such as Cancer Research, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Anna-Maria Larsson

25 papers receiving 844 citations

Peers

Anna-Maria Larsson
María Vieito Spain
Nadège Vimond France
María Villalba Spain
Satoshi Muto Japan
Inge Lodewijckx Belgium
Jan Dominik Kuhlmann Germany
И. Г. Козлов Russia
Runbi Ji China
Kevin Zarrabi United States
Malaka Ameratunga Australia
María Vieito Spain
Anna-Maria Larsson
Citations per year, relative to Anna-Maria Larsson Anna-Maria Larsson (= 1×) peers María Vieito

Countries citing papers authored by Anna-Maria Larsson

Since Specialization
Citations

This map shows the geographic impact of Anna-Maria Larsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna-Maria Larsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna-Maria Larsson more than expected).

Fields of papers citing papers by Anna-Maria Larsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna-Maria Larsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna-Maria Larsson. The network helps show where Anna-Maria Larsson may publish in the future.

Co-authorship network of co-authors of Anna-Maria Larsson

This figure shows the co-authorship network connecting the top 25 collaborators of Anna-Maria Larsson. A scholar is included among the top collaborators of Anna-Maria Larsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna-Maria Larsson. Anna-Maria Larsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rydén, Lisa, et al.. (2025). Prognostic relevance of CD163+ immune cells in patients with metastatic breast cancer. Cancer Immunology Immunotherapy. 74(2). 42–42.
2.
Larsson, Anna-Maria, et al.. (2025). Cancer rehabilitation in clinical practice: a qualitative study exploring contact nurses’ views on prerequisites. BMC Nursing. 24(1). 223–223. 1 indexed citations
3.
4.
Lång, Kristina, et al.. (2024). Mammographic features at primary breast cancer diagnosis in relation to recurrence-free survival. The Breast. 75. 103736–103736. 1 indexed citations
5.
Larsson, Anna-Maria, et al.. (2024). Gene expression in metastatic breast cancer—patterns in primary tumors and metastatic tissue with prognostic potential. Frontiers in Molecular Biosciences. 10. 1343979–1343979. 4 indexed citations
6.
7.
Borg, Sixten, et al.. (2023). Performance of standardized cancer patient pathways in Sweden visualized using observational data and a state-transition model. Scientific Reports. 13(1). 19535–19535. 1 indexed citations
8.
Παπαδάκος, Κωνσταντίνος Σ., Catharina Hagerling, Lisa Rydén, Anna-Maria Larsson, & Anna M. Blom. (2021). High Levels of Expression of Cartilage Oligomeric Matrix Protein in Lymph Node Metastases in Breast Cancer Are Associated with Reduced Survival. Cancers. 13(23). 5876–5876. 10 indexed citations
9.
Larsson, Anna-Maria, Carina Forsare, Kristina Aaltonen, et al.. (2021). PAM50 Intrinsic Subtype Profiles in Primary and Metastatic Breast Cancer Show a Significant Shift toward More Aggressive Subtypes with Prognostic Implications. Cancers. 13(7). 1592–1592. 13 indexed citations
10.
Sandsveden, Malte, et al.. (2020). Mammographic tumour appearance is related to clinicopathological factors and surrogate molecular breast cancer subtype. Scientific Reports. 10(1). 20814–20814. 22 indexed citations
11.
Larsson, Anna-Maria, Pär‐Ola Bendahl, Kristina Aaltonen, et al.. (2020). Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer. Scientific Reports. 10(1). 4484–4484. 15 indexed citations
12.
Bergenfelz, Caroline, et al.. (2020). Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer. Cancer Immunology Immunotherapy. 69(3). 435–448. 54 indexed citations
13.
Larsson, Anna-Maria, Sara Jansson, Pär‐Ola Bendahl, et al.. (2018). Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial. Breast Cancer Research. 20(1). 48–48. 91 indexed citations
14.
15.
Jansson, Sara, Pär‐Ola Bendahl, Anna-Maria Larsson, Kristina Aaltonen, & Lisa Rydén. (2016). Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort. BMC Cancer. 16(1). 433–433. 127 indexed citations
16.
Larsson, Anna-Maria, Mats E. Johansson, Sakarias Wangefjord, et al.. (2011). Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer. British Journal of Cancer. 105(5). 666–672. 81 indexed citations
17.
Larsson, Anna-Maria, Karin Jirström, Erik Fredlund, et al.. (2009). Erythropoietin Receptor Expression and Correlation to Tamoxifen Response and Prognosis in Breast Cancer. Clinical Cancer Research. 15(17). 5552–5559. 21 indexed citations
18.
Larsson, Anna-Maria, Linda Holmquist Mengelbier, Esther Bridges, et al.. (2008). Hypoxia-Inducible Factor-2α Correlates to Distant Recurrence and Poor Outcome in Invasive Breast Cancer. Cancer Research. 68(22). 9212–9220. 111 indexed citations
19.
Kressner, Ulf, Bengt Glimelius, R. Bergström, et al.. (1998). Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer. British Journal of Cancer. 77(11). 1848–1851. 48 indexed citations
20.
Larsson, Anna-Maria & Birger Åstedt. (1985). Immunohistochemical localisation of tissue plasminogen activator and urokinase in the vessel wall.. Journal of Clinical Pathology. 38(2). 140–145. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Vieito Breakdown of academic impact, for papers by Nadège Vimond Breakdown of academic impact, for papers by María Villalba Breakdown of academic impact, for papers by Satoshi Muto Breakdown of academic impact, for papers by Inge Lodewijckx Breakdown of academic impact, for papers by Jan Dominik Kuhlmann Breakdown of academic impact, for papers by И. Г. Козлов Breakdown of academic impact, for papers by Runbi Ji Breakdown of academic impact, for papers by Kevin Zarrabi Breakdown of academic impact, for papers by Malaka Ameratunga
Rankless by CCL
2026